NCT01446003View on ClinicalTrials.gov

A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 25, 2011

Primary Completion Date

February 18, 2012

Study Completion Date

March 3, 2012

Conditions
Hypertension
Interventions
DRUG

MK-8457

10 x 10-mg capsule BID for 10 days

DRUG

Placebo for MK-8457

10 x 10-mg capsule BID for 10 days

Trial Locations (2)

Unknown

Call for Information, Miramar

Call for Information, Tacoma

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01446003 - A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1) | Biotech Hunter | Biotech Hunter